GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » EV-to-Revenue

Modern Chinese Medicine Group Co (HKSE:01643) EV-to-Revenue : -0.23 (As of May. 30, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Modern Chinese Medicine Group Co's enterprise value is HK$-86.4 Mil. Modern Chinese Medicine Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$376.3 Mil. Therefore, Modern Chinese Medicine Group Co's EV-to-Revenue for today is -0.23.

The historical rank and industry rank for Modern Chinese Medicine Group Co's EV-to-Revenue or its related term are showing as below:

HKSE:01643' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.35   Med: 0.13   Max: 1.85
Current: -0.23

During the past 7 years, the highest EV-to-Revenue of Modern Chinese Medicine Group Co was 1.85. The lowest was -0.35. And the median was 0.13.

HKSE:01643's EV-to-Revenue is ranked better than
99.02% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.265 vs HKSE:01643: -0.23

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-30), Modern Chinese Medicine Group Co's stock price is HK$0.38. Modern Chinese Medicine Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.63. Therefore, Modern Chinese Medicine Group Co's PS Ratio for today is 0.61.


Modern Chinese Medicine Group Co EV-to-Revenue Historical Data

The historical data trend for Modern Chinese Medicine Group Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modern Chinese Medicine Group Co EV-to-Revenue Chart

Modern Chinese Medicine Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - 0.64 0.03 -0.29

Modern Chinese Medicine Group Co Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.64 - 0.03 - -0.29

Competitive Comparison of Modern Chinese Medicine Group Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Chinese Medicine Group Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's EV-to-Revenue falls into.



Modern Chinese Medicine Group Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Modern Chinese Medicine Group Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-86.440/376.342
=-0.23

Modern Chinese Medicine Group Co's current Enterprise Value is HK$-86.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Modern Chinese Medicine Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$376.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modern Chinese Medicine Group Co  (HKSE:01643) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Modern Chinese Medicine Group Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.38/0.627
=0.61

Modern Chinese Medicine Group Co's share price for today is HK$0.38.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.63.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Modern Chinese Medicine Group Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Modern Chinese Medicine Group Co (HKSE:01643) Business Description

Traded in Other Exchanges
N/A
Address
No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.
Executives
Sun Xinlei 2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si 2101 Beneficial owner
Xie Wei 2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co (HKSE:01643) Headlines

No Headlines